Frequently asked questions about naloxone: Part 1

Abstract

Are patients and community members asking complicated questions about naloxone? The goal of this 3-part informational series is to increase pharmacists' knowledge on the frequently asked questions about naloxone, so that they can fill their own knowledge gaps as well as those of their patients. Pharmacists are key to ensuring all those at risk of an opioid overdose, or who are in a position to help, have naloxone and know how to use it. Beyond the signs and symptoms of opioid toxicity, naloxone administration, and the importance of calling 911, pharmacists can also be a resource for emerging research about naloxone and countering myths about it. In this series, we will be addressing real-world questions from pharmacists, service providers and community members about naloxone.

Protocol for the Optimizing Naloxone Dispensing in Pharmacies (ONDP) Online Continuing Education Program: A Randomized Controlled Trial

“…The answers to these FAQs were compiled through a series of literature reviews and can be found in the special series of the Canadian Pharmacists Journal. They are aimed at correcting misinformation and knowledge gaps related to naloxone [44][45][46]. This module will provide pharmacists with the tools needed to answer FAQs from patients and colleagues and correct any inaccurate perceptions pharmacists may have about naloxone.…”